We synthesize mechanisms linking menopausal biology to increased risk of sarcopenic obesity: obesity-driven inflammation, adipokine dysregulation, and lipotoxic flux that impair insulin-AKT signaling and metabolic flexibility, coupled with reduced contractile/endocrine muscle output that worsens adipose phenotype. The gene discussed is AKT1; the disease is Obesity.